YPL-1101
N/A
Report date: 2023/02/09 18:30:52
NME
Base Information
Drug NameYPL-1101
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator Companies1 A Pharma Gmbh
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A